[Front Line Genomics] Cancer Genomics: The impact of genomics on cancer research, diagnostics, therapeutics and clinical care

Cancer Genomics: The Impact of Genomics on Cancer Research, Diagnostics, Therapeutics and Clinical Care

This latest report from Front Line Genomics showcases progress made across the cancer genomics field, areas of transformative research and how this could translate into clinic in the future.

Contributors include Anju Kulkarni, Consultant Clinical Geneticist at Guy’s and St Thomas’ NHS Foundation Trust, who explores the benefits of tumour sequencing in the recognition of hereditary cancer.

Leave a Comment

Your email address will not be published. Required fields are marked *

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.